Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
CONCLUSION: Patients with prior respiratory diseases were globally less likely to be hospitalised for COVID-19 than for influenza but were at higher risk of developing severe COVID-19 and had a higher mortality rate compared to influenza patients and patients without a history of respiratory illness.Our data suggest that these patients should have priority access to SARS-CoV2 vaccination.PMID:34016619 | DOI:10.1183/13993003.04474-2020
Source: Respiratory Care - Category: Respiratory Medicine Authors: Guillaume Beltramo Jonathan Cottenet Anne-Sophie Mariet Marjolaine Georges Lionel Piroth Pascale Tubert-Bitter Philippe Bonniaud Catherine Quantin Source Type: research
More News: Asthma | Cancer | Cancer & Oncology | Cancer Vaccines | Chronic Obstructive Pulmonary | COVID-19 | Cystic Fibrosis | Emphysema | Epidemics | Epidemiology | Hypertension | Influenza | Influenza Vaccine | Intensive Care | Lung Cancer | Outbreaks | Pneomococcal Vaccine | Pneumonia | Pulmonary Hypertension | Pulmonary Thromboembolism | Respiratory Medicine | SARS | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study | Vaccines